minomic logo2

 

Minomic International is committed to developing and commercialising biomarkers for diagnosis and treatment of major diseases. 

As such, Minomic International will continue to seek opportunities to work with developers and the industry as a whole. 

For more information on upcoming diagnostics that Minomic International will be managing the commercialisation of, please contact info@minomic.com

 

 

PROSTATE CANCER TESTING SET TO INCREASE
Prostate Cancer tests are set to increase dramatically with the aid of a new diagnostic being developed...

 
Read More :
 

MINOMIC INTERNATIONAL TO COMMERCIALISE PROSTATE CANCER AND DIABETES (TYPE 2) DIAGNOSTICS
Minomic International Limited has commenced its international marketing....

 
Read More :